Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Debt (2017 - 2022)

Historic Non-Current Debt for Inspire Medical Systems (INSP) over the last 6 years, with Q2 2022 value amounting to $9.8 million.

  • Inspire Medical Systems' Non-Current Debt fell 5507.09% to $9.8 million in Q2 2022 from the same period last year, while for Jun 2022 it was $9.8 million, marking a year-over-year decrease of 5507.09%. This contributed to the annual value of $15.8 million for FY2021, which is 3615.53% down from last year.
  • As of Q2 2022, Inspire Medical Systems' Non-Current Debt stood at $9.8 million, which was down 5507.09% from $12.8 million recorded in Q1 2022.
  • Over the past 5 years, Inspire Medical Systems' Non-Current Debt peaked at $24.9 million during Q4 2018, and registered a low of $9.8 million during Q2 2022.
  • Over the past 5 years, Inspire Medical Systems' median Non-Current Debt value was $24.4 million (recorded in 2019), while the average stood at $22.0 million.
  • In the last 5 years, Inspire Medical Systems' Non-Current Debt soared by 5143.38% in 2018 and then crashed by 5507.09% in 2022.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Non-Current Debt stood at $24.9 million in 2018, then dropped by 1.62% to $24.5 million in 2019, then rose by 0.91% to $24.7 million in 2020, then crashed by 36.16% to $15.8 million in 2021, then tumbled by 38.0% to $9.8 million in 2022.
  • Its last three reported values are $9.8 million in Q2 2022, $12.8 million for Q1 2022, and $15.8 million during Q4 2021.